The startup operates an integrated research organization that embeds clinical trials at the point of care, collaborating with healthcare providers to enhance patient participation and streamline data collection. This approach reduces the drug development timeline, improving access to clinical trials and outcomes for healthcare organizations.
Funding
$53.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional clinical trial models often face challenges in patient enrollment, data collection, and efficient execution, leading to delays in drug development and limited access to cutting-edge treatments for patients. Healthcare organizations may lack the infrastructure and expertise to effectively integrate clinical research into their care delivery systems.
Solution
Javara operates as an integrated research organization (IRO), embedding clinical trial infrastructure and personnel directly within healthcare provider networks. This approach enhances patient access to clinical trials at the point of care, streamlines the research process, and accelerates drug development timelines. By integrating research into routine care, Javara facilitates greater patient participation, improves data quality, and delivers more reliable results. The IRO model provides healthcare organizations with the resources and support needed to conduct clinical trials without the administrative burden or upfront investment.
Target Audience
Javara serves biopharmaceutical companies, contract research organizations (CROs), and healthcare organizations seeking to improve clinical trial efficiency, increase patient access, and generate high-quality data.
Features
- On-site clinical trial staff and infrastructure embedded within healthcare organizations
- Scalable research model providing access to diverse patient populations
- Streamlined data collection and management processes
- Expertise in navigating regulatory requirements and compliance
- Enhanced patient engagement and participation in clinical trials
- Improved efficiency and reduced timelines for clinical trial completion